Belatacept Conversion in Kidney After Liver Transplantation

BACKGROUND. Costimulatory blockade with belatacept has demonstrated long-term benefits in renal transplantation, but de novo use in liver transplant recipients has resulted in increased rejection, graft loss, and death. However, belatacept conversion as a calcineurin inhibitor (CNI) avoidance strate...

Descripción completa

Detalles Bibliográficos
Autores principales: Cristea, Octav, Karadkhele, Geeta, Kitchens, William H., Vasanth, Payaswini, Larsen, Christian P., Badell, Idelberto R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Kidney Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547931/
https://www.ncbi.nlm.nih.gov/pubmed/34712780
http://dx.doi.org/10.1097/TXD.0000000000001229

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547931/
https://www.ncbi.nlm.nih.gov/pubmed/34712780
http://dx.doi.org/10.1097/TXD.0000000000001229

Ejemplares similares